Cite
Roy Chowdhury U, Kudgus RA, Holman BH, et al. Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates. J Ocul Pharmacol Ther. 2021;37(5):251-260doi: 10.1089/jop.2020.0137.
Roy Chowdhury, U., Kudgus, R. A., Holman, B. H., Rinkoski, T. A., Hann, C. R., Bahler, C. K., McCloud, E., Appt, S. E., Reid, J. M., Dosa, P. I., & Fautsch, M. P. (2021). Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 37(5), 251-260. https://doi.org/10.1089/jop.2020.0137
Roy Chowdhury, Uttio, et al. "Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates." Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics vol. 37,5 (2021): 251-260. doi: https://doi.org/10.1089/jop.2020.0137
Roy Chowdhury U, Kudgus RA, Holman BH, Rinkoski TA, Hann CR, Bahler CK, McCloud E, Appt SE, Reid JM, Dosa PI, Fautsch MP. Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates. J Ocul Pharmacol Ther. 2021 Jun;37(5):251-260. doi: 10.1089/jop.2020.0137. Epub 2021 Mar 30. PMID: 33784195; PMCID: PMC8215408.
Copy
Download .nbib